Chips and Qi: microcomponent-based analysis in traditional Chinese medicine

Area of Science:

• Pharmacology and Pharmacognosy
• Molecular Biology
• Biotechnology

Background:

• Traditional Chinese Medicine (TCM) has undergone extensive research, demonstrating effectiveness and safety.
• Challenges exist in identifying TCM components, with some being toxic or difficult to authenticate.
• DNA polymorphism-based assays offer a modern solution for identifying herbal medicines.

Purpose of the Study:

• To develop and apply DNA-based methods for the precise identification of Traditional Chinese Medicine materials.
• To showcase the fabrication and utility of integrated "lab-on-a-chip" devices for TCM analysis.
• To specifically identify toxic medicinal plants using DNA sequencing on microarrays.

Main Methods:

• Utilized DNA polymorphism-based assays, including polymerase chain reaction (PCR) for DNA amplification.
• Employed gel electrophoresis, sequencing, and hybridization with species-specific probes for analysis.
• Developed and applied silicon-based PCR microreactors and DNA microarrays on a microchip device.

Main Results:

• Successfully demonstrated DNA-based identification of TCM materials.
• Reported the application of a "lab-on-a-chip" device integrating sample preparation, amplification, and analysis.
• Validated the use of PCR microreactors and DNA microarrays for identifying toxic medicinal plants via DNA sequencing.

Conclusions:

• DNA-based identification methods provide a reliable approach for authenticating TCM.
• Microchip-based "lab-on-a-chip" technology offers a streamlined and integrated platform for TCM analysis.
• This technology is crucial for enhancing the safety and quality control of Traditional Chinese Medicine.